Haematologic Technologies is Drug Discovery in United States that focus on GMP compliant business. Founded in 1987. They cover business area such as provider, biologic product, development and testing service, protein, antibody, associate reagent, thrombosis research, in-vitro diagnostic application, coagulation reagent, bioanalytical service, pre-clinical development, release, commercial biologic.
1987
( 37 years old in 2024 )
GMP Compliant
-
57 River Road
Essex Junction, VT 05452
United States
Private
providerbiologic productdevelopment and testing serviceproteinantibodyassociate reagentthrombosis researchin-vitro diagnostic applicationcoagulation reagentbioanalytical servicepre-clinical developmentreleasecommercial biologic
* We use standard office opening hours in near Haematologic Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Haematologic Technologies is Drug Discovery business from United States that founded in 1987 (37 years old in 2024), Haematologic Technologies business is focusing on GMP Compliant.
Haematologic Technologies headquarter office and corporate office address is located in 57 River Road Essex Junction, VT 05452 United States.
Haematologic Technologies was founded in United States.
In 2024, Haematologic Technologies is currently focus on GMP compliant sector.
Above is snippet of Google Trends for "GMP compliant" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Haematologic Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
